ReviewHIV/AIDS (Auckland, N.Z.)2016

Profile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to date.

Thomas Whitfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.